ImmunoPrecise Antibodies
IPA
#9890
Rank
A$32.18 M
Marketcap
$0.70
Share price
-3.00%
Change (1 day)
-61.60%
Change (1 year)

Earnings for ImmunoPrecise Antibodies (IPA)

Earnings in 2025 (TTM): -A$56.52 Million

According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are A$17.17 Million. In 2024 the company made an earning of -A$56.49 Million a decrease over its 2023 earnings that were of -A$18.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoPrecise Antibodies from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$56.52 Million0.05%
2024 -A$56.49 Million211.9%
2023 -A$18.12 Million-41.74%
2022 -A$31.09 Million63.41%
2021 -A$19.03 Million519.54%
2020 -A$3.08 Million-58.53%
2019 -A$7.41 Million37.19%
2018 -A$5.4 Million6.4%
2017 -A$5.08 Million-2968.28%
2016 A$0.17 M-614.98%
2015 -A$0.04 Million-60.32%
2014 -A$0.09 Million-186.81%
2013 A$0.09 M-166.36%
2012 -A$0.16 Million-59.28%
2011 -A$0.37 Million
2004 -A$0.22 Million-41.04%
2003 -A$0.37 Million129.66%
2002 -A$0.16 Million-32.91%
2001 -A$0.24 Million50.61%
2000 -A$0.16 Million-16.18%
1999 -A$0.19 Million-1.56%
1998 -A$0.19 Million-39.38%
1997 -A$0.32 Million